GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CEBPD | hg38_v1_chr8_-_47738153_47738173 | 0.41 | 4.8e-10 | Click! |
CEBPE | hg38_v1_chr14_-_23119248_23119265 | -0.12 | 8.4e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_91423819 Show fit | 42.01 |
ENST00000297689.4
|
nuclear factor, interleukin 3 regulated |
|
chr5_+_96662214 Show fit | 34.61 |
ENST00000395812.6
|
calpastatin |
|
chr5_+_96662366 Show fit | 33.15 |
ENST00000675179.1
ENST00000421689.6 ENST00000674984.1 ENST00000512620.5 |
calpastatin |
|
chr16_-_84618041 Show fit | 32.75 |
ENST00000564057.1
|
coactosin like F-actin binding protein 1 |
|
chr5_+_96662314 Show fit | 32.63 |
ENST00000674702.1
|
calpastatin |
|
chr16_-_84618067 Show fit | 32.30 |
ENST00000262428.5
|
coactosin like F-actin binding protein 1 |
|
chr15_+_45635017 Show fit | 31.49 |
ENST00000260324.12
|
sulfide quinone oxidoreductase |
|
chr5_+_96662046 Show fit | 28.59 |
ENST00000338252.7
ENST00000508830.5 |
calpastatin |
|
chr3_+_157436842 Show fit | 27.54 |
ENST00000295927.4
|
pentraxin 3 |
|
chr19_-_40465760 Show fit | 27.33 |
ENST00000643519.1
|
biliverdin reductase B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 129.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.8 | 75.1 | GO:0050832 | defense response to fungus(GO:0050832) |
4.5 | 58.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.7 | 51.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
6.9 | 48.6 | GO:1990822 | regulation of arginine metabolic process(GO:0000821) basic amino acid transmembrane transport(GO:1990822) |
1.0 | 42.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.3 | 36.0 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
4.9 | 34.1 | GO:0034201 | response to oleic acid(GO:0034201) |
7.9 | 31.5 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
1.8 | 27.4 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 112.7 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
5.7 | 51.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 49.8 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 45.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 45.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 37.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 32.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.3 | 26.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 26.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
5.0 | 24.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.9 | 129.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
14.5 | 58.0 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
1.3 | 51.7 | GO:0008143 | poly(A) binding(GO:0008143) |
4.0 | 48.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 43.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 41.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 38.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
2.2 | 37.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.4 | 34.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 31.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 31.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 27.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 26.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.7 | 25.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.3 | 24.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 22.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 22.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 15.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 14.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 14.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 61.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.9 | 44.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 37.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
2.0 | 37.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 34.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.9 | 34.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 29.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 28.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.6 | 27.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.7 | 22.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |